[{"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-001", "question": "A 65-year-old woman with Crohn's disease undergoes ileocecal resection. Pathology shows transmural inflammation and non-caseating granulomas. Postoperatively, she develops recurrent diarrhea and weight loss. What is the most likely complication?", "options": ["Short bowel syndrome", "Anastomotic stricture", "Bacterial overgrowth", "Vitamin B12 deficiency", "Bile acid malabsorption"], "answer": "E", "answer_index": 4, "explanation": "Resection of the terminal ileum in Crohn's disease disrupts bile acid reabsorption, leading to bile acid malabsorption and diarrhea. Short bowel syndrome requires more extensive resection. Vitamin B12 deficiency may occur but typically presents later with anemia, not acute diarrhea.", "generator_model": "grok-4-0709", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed130", "source_question_id": "20251216T182308874Z_grok-4-0709_seed130-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed130.jsonl", "pred": "E", "model_outputs": "The patient has undergone ileocecal resection for Crohn's disease. The ileocecal region is critical for several absorptive and barrier functions. The symptoms are recurrent diarrhea and weight loss. Let's evaluate each option:\n\nA. Short bowel syndrome: This occurs when a significant portion of the small intestine is removed, leading to generalized malabsorption of nutrients, fluids, and electrolytes. While ileocecal resection can contribute to a reduced bowel length, the severity of short bowel syndrome depends on the total length of the small intestine resected. It can cause diarrhea and weight loss, but it's dependent on the extent of resection.\n\nB. Anastomotic stricture: A stricture is a narrowing at the surgical connection. This typically causes obstructive symptoms such as abdominal pain, nausea, vomiting, and constipation or obstipation. While it can lead to malabsorption if severe and prolonged, diarrhea is not the primary symptom, and obstructive symptoms would usually be more prominent.\n\nC. Bacterial overgrowth: The ileocecal valve prevents the retrograde flow of colonic bacteria into the small intestine. Its removal, along with potential altered motility or stasis in the remaining bowel, can lead to a proliferation of bacteria in the small intestine (SIBO). SIBO can cause diarrhea, bloating, malabsorption, and weight loss by consuming nutrients, deconjugating bile acids, and damaging the intestinal mucosa. This is a significant possibility after ileocecal resection.\n\nD. Vitamin B12 deficiency: Vitamin B12 is absorbed primarily in the terminal ileum. Resection of the terminal ileum directly impairs B12 absorption. However, vitamin B12 deficiency typically manifests as megaloblastic anemia, fatigue, and neurological symptoms. While chronic malabsorption can contribute to weight loss, diarrhea is not the primary direct symptom of B12 deficiency itself, and it usually develops over time rather than presenting immediately postoperatively.\n\nE. Bile acid malabsorption: The terminal ileum is the primary site for the reabsorption of bile acids. After ileocecal resection, bile acids are not reabsorbed efficiently and pass into the colon. In the colon, these bile acids stimulate water and electrolyte secretion, leading to osmotic diarrhea. This is a very common complication after resection of the terminal ileum and is often the cause of watery diarrhea following such surgery. Significant diarrhea can lead to malabsorption of other nutrients and contribute to weight loss.\n\nComparing options C and E: Both bacterial overgrowth and bile acid malabsorption are common complications of ileocecal resection that can cause diarrhea and weight loss. However, bile acid malabsorption is often cited as the *most common* and direct cause of diarrhea following removal of the terminal ileum, as the loss of absorptive capacity is an immediate consequence of the resection. Bacterial overgrowth is also frequent but may be more dependent on other factors like residual disease or specific patterns of motility disturbance. Given the direct anatomical impact of resecting the terminal ileum on bile acid enterohepatic circulation, bile acid malabsorption is a highly likely explanation for the patient's symptoms.\n\nThe final answer is $\\boxed{E}$."}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-002", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "source_question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed126.jsonl", "pred": "B", "model_outputs": "The question describes a 45-year-old woman with rheumatoid arthritis (RA) who is being treated with methotrexate (MTX). She presents with progressive dyspnea and dry cough, which are symptoms suggestive of interstitial lung disease (ILD). High-resolution CT (HRCT) findings show subpleural reticular opacities and traction bronchiectasis, and pulmonary function tests (PFTs) reveal a restrictive pattern.\n\nLet's evaluate the options:\n\nA. Methotrexate-induced interstitial lung disease (MTX-ILD): Methotrexate is a known cause of drug-induced lung disease, which can manifest with various patterns, including a usual interstitial pneumonia (UIP)-like pattern, hypersensitivity pneumonitis, or non-specific interstitial pneumonia (NSIP). The symptoms, HRCT findings (reticular opacities, traction bronchiectasis suggesting fibrosis), and restrictive PFTs are consistent with ILD. Therefore, MTX-ILD is a plausible diagnosis.\n\nB. Rheumatoid arthritis-associated usual interstitial pneumonia (RA-associated UIP): Rheumatoid arthritis itself is a well-established cause of ILD, which frequently exhibits a UIP pattern on HRCT. The HRCT findings described (subpleural reticular opacities and traction bronchiectasis) are characteristic of UIP. RA-ILD is a recognized complication of RA.\n\nC. Hypersensitivity pneumonitis (HP) from environmental exposure: HP can cause ILD with similar symptoms and radiological findings. However, HP is typically triggered by exposure to an inhaled antigen, and no such exposure is mentioned in the clinical vignette. This makes it less likely than diagnoses directly related to the patient's known conditions.\n\nD. Non-specific interstitial pneumonia (NSIP): NSIP can cause restrictive ILD with similar symptoms. While RA can be associated with ILD patterns other than UIP, NSIP typically shows more ground-glass opacities and less prominent reticulation and honeycombing/traction bronchiectasis at early stages compared to UIP. The described findings of \"subpleural reticular opacities and traction bronchiectasis\" are more suggestive of UIP than NSIP.\n\nE. Cryptogenic organizing pneumonia (COP): COP (now often referred to as idiopathic BOOP) typically presents with consolidations, ground-glass opacities (often with a reverse halo sign), and a more patchy distribution, which is different from the reticular opacities and traction bronchiectasis described.\n\nComparing options A and B:\nBoth RA-ILD and MTX-ILD can present with similar clinical and radiological features, including a UIP pattern. It is often difficult to definitively distinguish between the two, especially when a patient has RA and is treated with MTX. However, the HRCT findings provided – subpleural reticular opacities and traction bronchiectasis – are highly suggestive of the UIP pattern. Usual interstitial pneumonia is the most common histological/radiological pattern seen in RA-associated ILD. While MTX-ILD can also mimic UIP, RA itself is a primary disease process that is strongly associated with the development of ILD, particularly with a UIP pattern. Given that the HRCT findings are characteristic of UIP, and RA is a known cause of ILD presenting as UIP, \"Rheumatoid arthritis-associated usual interstitial pneumonia\" (B) directly links the underlying disease to the observed pattern. While MTX is a possible cause, the description points strongly to a UIP pattern, which is a hallmark of RA-ILD. Therefore, RA-associated UIP is often considered the primary diagnosis in such cases, especially if there is no clear temporal relationship to MTX initiation that strongly implicates the drug.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-003", "question": "A 55-year-old immunocompromised patient with lung transplant develops dyspnea and ground-glass opacities on CT. Bronchoalveolar lavage PCR is positive for Pneumocystis jirovecii, but serum beta-D-glucan is negative. He is on trimethoprim-sulfamethoxazole prophylaxis. What explains the breakthrough infection?", "options": ["Dihydropteroate synthase gene mutation", "Non-adherence to prophylaxis", "Concurrent cytomegalovirus co-infection", "Inadequate dosing in obesity", "Atovaquone cross-resistance"], "answer": "A", "answer_index": 0, "explanation": "Mutations in the dihydropteroate synthase gene confer resistance to sulfamethoxazole in Pneumocystis, leading to breakthrough despite prophylaxis in immunocompromised hosts. Non-adherence is common but less likely with negative beta-D-glucan suggesting low burden. CMV co-infection exacerbates but does not cause resistance.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "topics_mapped", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "source_question_id": "20251201T041413890Z_grok-4-0709_seed124-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed124.jsonl", "pred": "A", "model_outputs": "The patient has a breakthrough *Pneumocystis jirovecii* pneumonia (PCP) infection despite being on trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis. TMP-SMX is a standard prophylactic agent for PCP. The mechanism of action of TMP-SMX is inhibition of dihydropteroate synthase, which is essential for folate synthesis in *P. jirovecii*.\n\nLet's evaluate the options:\nA. Dihydropteroate synthase gene mutation: Mutations in the dihydropteroate synthase (DHPS) gene of *P. jirovecii* can confer resistance to TMP-SMX by altering the enzyme's affinity for the drug. This is a known mechanism for TMP-SMX failure and breakthrough PCP infections.\n\nB. Non-adherence to prophylaxis: While non-adherence is a common cause of treatment or prophylaxis failure, the vignette does not provide any information to suggest this.\n\nC. Concurrent cytomegalovirus co-infection: CMV co-infection can increase immunosuppression and thus the risk of opportunistic infections like PCP. However, CMV infection itself does not cause PCP, nor does it explain the failure of TMP-SMX prophylaxis against *P. jirovecii*.\n\nD. Inadequate dosing in obesity: Obesity can affect drug pharmacokinetics. While this could theoretically lead to sub-therapeutic drug levels, it's a less direct explanation for prophylaxis failure compared to an intrinsic resistance mechanism of the pathogen. Standard prophylaxis doses are often fixed and may not always be adjusted for extreme body weights.\n\nE. Atovaquone cross-resistance: Atovaquone is an alternative drug for PCP prophylaxis and treatment, acting on a different pathway (ubiquinone biosynthesis). Cross-resistance between TMP-SMX and atovaquone is generally not observed by virtue of direct resistance mechanisms. Moreover, the patient is on TMP-SMX prophylaxis, not atovaquone.\n\nGiven that the patient is on TMP-SMX prophylaxis, the most direct and biologically sound explanation for breakthrough PCP is that the infecting strain of *P. jirovecii* has developed or harbors mutations conferring resistance to TMP-SMX via its target enzyme, dihydropteroate synthase.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-004", "question": "A 9-year-old girl with neurofibromatosis type 1 presents with hypertension and headaches. MRI reveals a pheochromocytoma and bilateral renal artery stenosis. Genetic analysis confirms NF1 mutation. What is the most appropriate initial management for her hypertension prior to surgical intervention?", "options": ["Alpha-blockade with phenoxybenzamine followed by beta-blockade", "Angiotensin-converting enzyme inhibitor monotherapy", "Percutaneous renal artery angioplasty", "Calcium channel blocker initiation", "Surgical resection of pheochromocytoma without preoperative preparation"], "answer": "A", "answer_index": 0, "explanation": "In pheochromocytoma associated with NF1, preoperative alpha-blockade followed by beta-blockade is essential to prevent hypertensive crisis during surgery. ACE inhibitors may exacerbate renal stenosis issues, and angioplasty or surgery without preparation risks catecholamine surge. Calcium channel blockers are not sufficient alone.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "NOT FOR CLINICAL USE.\n\nThe patient presents with hypertension and headaches, findings compatible with excess catecholamine release from a pheochromocytoma. The presence of neurofibromatosis type 1 (NF1) is a known risk factor for pheochromocytoma. The MRI confirms the pheochromocytoma and also reveals bilateral renal artery stenosis, which can also cause or exacerbate hypertension. The question asks for the most appropriate initial management of her hypertension prior to surgical intervention.\n\nSurgical resection is the definitive treatment for pheochromocytoma, but it carries a significant risk of hypertensive crisis, arrhythmias, and other cardiovascular complications if the patient is not adequately prepared. The standard preoperative management for pheochromocytoma involves:\n1.  Alpha-adrenergic blockade: This is the crucial first step to control blood pressure and prevent intraoperative hypertensive crises by blocking the vasoconstrictive effects of circulating catecholamines. Commonly used agents include phenoxybenzamine (a non-selective, irreversible alpha-blocker) or selective alpha-1 blockers. Phenoxybenzamine is often preferred for its longer duration of action in surgical preparation.\n2.  Beta-adrenergic blockade: This is added *after* adequate alpha-blockade has been established (usually 2-3 days) to control tachycardia and arrhythmias. Beta-blockers alone or initiated before alpha-blockade can lead to unopposed alpha-stimulation and a paradoxical exacerbation of hypertension and hypertensive crisis.\n\nThe presence of bilateral renal artery stenosis also contributes to hypertension and requires management. However, the immediate and most life-threatening risk in this scenario, especially concerning surgical intervention for the pheochromocytoma, is the potential for a catecholamine-induced hypertensive crisis. Therefore, addressing the pheochromocytoma's contribution to hypertension takes precedence for preoperative preparation.\n\nLet's evaluate the options:\nA. Alpha-blockade with phenoxybenzamine followed by beta-blockade: This is the standard and essential preoperative preparation for pheochromocytoma. It addresses the most acute risk to the patient and prepares her for surgery.\nB. Angiotensin-converting enzyme inhibitor monotherapy: ACE inhibitors can be effective for hypertension, but they are not the primary treatment for the acute risk posed by a pheochromocytoma, and their use in bilateral renal artery stenosis warrants caution regarding renal function, although they might be part of the ongoing management.\nC. Percutaneous renal artery angioplasty: This is an interventional procedure for renal artery stenosis. While it may be part of the long-term management, it is not the initial pharmacological management for hypertension prior to pheochromocytoma surgery.\nD. Calcium channel blocker initiation: Calcium channel blockers are useful antihypertensives and can be used in patients with pheochromocytoma and renal artery stenosis. However, alpha-blockade is more specifically targeted at mitigating the risks of catecholamine excess from the pheochromocytoma and is considered the cornerstone of preoperative preparation.\nE. Surgical resection of pheochromocytoma without preoperative preparation: This is contraindicated due to the high risk of severe complications.\n\nGiven that the question asks for the *initial* management of hypertension *prior to surgical intervention* (which is presumed to be for the pheochromocytoma), the most appropriate step is to begin the standard preoperative pharmacological preparation for pheochromocytoma, which starts with alpha-blockade.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-005", "question": "In the emergency department, a 50-year-old man presents with severe abdominal pain and vomiting. CT scan shows acute pancreatitis with necrosis. He develops hypotension and acute kidney injury. Serum triglycerides are 1200 mg/dL. What is the most appropriate initial management for the hypertriglyceridemia?", "options": ["Plasmapheresis", "Insulin infusion", "Fibrates", "Niacin", "Statins"], "answer": "B", "answer_index": 1, "explanation": "Insulin infusion effectively lowers triglycerides in hypertriglyceridemic pancreatitis by enhancing lipoprotein lipase activity. Plasmapheresis is reserved for severe cases not responding to insulin. Fibrates, niacin, and statins are long-term therapies not suitable for acute management.", "generator_model": "grok-4-0709", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed127", "source_question_id": "20251201T041413890Z_grok-4-0709_seed127-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed127", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed127.jsonl", "pred": "B", "model_outputs": "NOT FOR CLINICAL USE.\nThe patient has severe hypertriglyceridemia (1200 mg/dL) complicated by acute pancreatitis and organ dysfunction (hypotension, AKI). Severe hypertriglyceridemia itself is a major risk factor for and cause of acute pancreatitis. In such cases, aggressive lowering of triglyceride levels is indicated.\n\nLet's evaluate the options:\nA. Plasmapheresis: This is an effective method for rapidly reducing triglyceride levels by removing triglyceride-rich lipoproteins from the blood. It is often used in cases of severe hypertriglyceridemia-induced pancreatitis, especially when there is organ dysfunction.\nB. Insulin infusion: Intravenous insulin administration helps to lower serum triglycerides by activating lipoprotein lipase, which promotes the clearance of triglyceride-rich lipoproteins, and by decreasing hepatic triglyceride synthesis. It is considered a highly effective and readily available method for managing severe hypertriglyceridemia, particularly in the context of acute pancreatitis, and is often preferred as an initial treatment due to its relative ease of administration and availability compared to plasmapheresis.\nC. Fibrates: Fibrates are oral medications used for chronic management of hypertriglyceridemia. They take time to work and are not appropriate for acute management in a crisis situation like severe pancreatitis with organ failure.\nD. Niacin: Niacin is also primarily used for chronic lipid management. It has a slower onset of action and is not indicated for acute management of severe hypertriglyceridemia-induced pancreatitis.\nE. Statins: Statins are primarily used to lower LDL cholesterol and have a less significant impact on severe hypertriglyceridemia compared to other agents. They are not the first-line treatment for acutely lowering very high triglyceride levels.\n\nBetween plasmapheresis and insulin infusion, both are considered effective. However, current guidelines and expert opinion often favor intravenous insulin infusion as the initial therapy for severe hypertriglyceridemia-induced pancreatitis because it is less invasive, more readily available, and can be initiated quickly in most acute care settings, especially in hemodynamically unstable patients. It effectively promotes triglyceride clearance when combined with appropriate fluid resuscitation and supportive care.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-006", "question": "A 29-year-old woman with polycystic ovary syndrome undergoes in vitro fertilization and develops abdominal distension, dyspnea, and oliguria 5 days post-embryo transfer. Ultrasound shows massive ascites and enlarged ovaries. Laboratory tests reveal hemoconcentration and hyponatremia. What is the most appropriate initial management?", "options": ["Intravenous albumin infusion and paracentesis", "Diuretic therapy with furosemide", "Heparin prophylaxis alone", "Expectant management at home", "Surgical ovarian detorsion"], "answer": "A", "answer_index": 0, "explanation": "Severe ovarian hyperstimulation syndrome requires fluid management with albumin for oncotic pressure and paracentesis for symptomatic relief. Diuretics worsen hypovolemia; heparin prevents thrombosis but is adjunctive. Expectant management risks deterioration; detorsion is for torsion, not OHSS.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "target_topic", "source_label_raw": "Obstetrics and Gynecology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-016", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "The patient presents with symptoms and signs highly suggestive of Ovarian Hyperstimulation Syndrome (OHSS), likely moderate to severe, following in vitro fertilization. Key features include abdominal distension, dyspnea, oliguria, massive ascites, enlarged ovaries, hemoconcentration, and hyponatremia. OHSS is characterized by increased vascular permeability, leading to a shift of fluid from the intravascular space into the peritoneal cavity (ascites) and pleural spaces, causing hypovolemia, hemoconcentration, electrolyte imbalances, and organ hypoperfusion (manifested as oliguria).\n\nLet's evaluate the management options:\nA.  Intravenous albumin infusion and paracentesis: Intravenous albumin is crucial in managing moderate to severe OHSS. Albumin acts as an oncotic agent, drawing fluid back into the intravascular space, thereby restoring circulating volume, improving renal perfusion, and counteracting hemoconcentration. Therapeutic paracentesis can relieve symptoms associated with massive ascites, such as abdominal discomfort and dyspnea, and removes fluid that can contribute to continued vascular leakage. This combination directly addresses the primary pathophysiological issues of fluid shift and hypovolemia.\n\nB.  Diuretic therapy with furosemide: Diuretics are generally contraindicated in OHSS, particularly in the presence of hemoconcentration and hypovolemia. Administering diuretics would further deplete intravascular volume, potentially worsening hypotension, renal function, and hemoconcentration.\n\nC.  Heparin prophylaxis alone: Thromboembolism is a significant complication of OHSS due to hemoconcentration, immobility, and inflammatory mediators. Heparin prophylaxis is important for preventing these complications. However, it does not address the primary problem of fluid shifts and hypovolemia that is causing the patient's acute symptoms.\n\nD.  Expectant management at home: The patient's symptoms (dyspnea, oliguria) and laboratory findings (hemoconcentration) indicate at least moderate to severe OHSS, which requires hospitalization for close monitoring and management of fluid status, electrolytes, and potential complications. Sending such a patient home is inappropriate and dangerous.\n\nE.  Surgical ovarian detorsion: While enlarged ovaries in OHSS can be at risk for torsion, the primary presentation described (abdominal distension, ascites, dyspnea, oliguria, hemoconcentration) is characteristic of OHSS itself, not ovarian torsion. Ovarian torsion typically presents with sudden, severe, often unilateral, sharp ovarian pain. While ovarian torsion is a possible complication, the initial management should focus on the presumed diagnosis of OHSS. Surgical intervention for torsion would only be considered if there is clear evidence and high suspicion of torsion causing ovarian ischemia.\n\nTherefore, addressing the fluid shifts and hypovolemia with intravenous albumin and managing symptomatic ascites with paracentesis is the most appropriate initial management for moderate to severe OHSS.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-007", "question": "A 32-year-old woman with schizophrenia on clozapine develops fever, tachycardia, and muscle rigidity. Laboratory findings include elevated creatine kinase and leukocytosis. Which rare adverse effect is most likely responsible, and what is the next step in management?", "options": ["Agranulocytosis; discontinue clozapine and start G-CSF", "Neuroleptic malignant syndrome; administer dantrolene and bromocriptine", "Serotonin syndrome; give cyproheptadine", "Catatonia; initiate electroconvulsive therapy", "Myocarditis; perform echocardiography and stop clozapine"], "answer": "B", "answer_index": 1, "explanation": "Neuroleptic malignant syndrome is the diagnosis, requiring immediate supportive care with dantrolene for rigidity and bromocriptine for dopamine agonism. Agranulocytosis presents with infection without rigidity, serotonin syndrome lacks CK elevation typically, catatonia is behavioral, and myocarditis involves cardiac symptoms primarily.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "B", "model_outputs": "The patient presents with a constellation of symptoms highly suggestive of Neuroleptic Malignant Syndrome (NMS). Key features of NMS include hyperthermia (fever), severe muscle rigidity (\"lead pipe\" rigidity), autonomic dysfunction (tachycardia is noted here), and altered mental status (not explicitly stated but often present). Laboratory findings commonly include elevated creatine kinase (CK) due to rhabdomyolysis, and leukocytosis. Clozapine, being an atypical antipsychotic, can precipitate NMS.\n\nLet's analyze why other options are less likely:\nA. Agranulocytosis: While clozapine is strongly associated with agranulocytosis (a severe drop in white blood cells), this typically presents with signs of infection (fever, sore throat, fatigue) and does not primarily involve muscle rigidity or significantly elevated CK.\nC. Serotonin syndrome: This is usually caused by interactions among serotonergic drugs. While clozapine has some serotonergic activity, NMS is a more direct and common concern related to neuroleptic blockade of dopamine receptors. The classic presentation with marked rigidity and high CK strongly favors NMS over serotonin syndrome.\nD. Catatonia: Catatonia can occur in schizophrenia and, in severe forms (malignant catatonia), can present with autonomic instability and fever. However, NMS is a specific drug-induced syndrome with a characteristic clinical picture, and discontinuing the offending agent and specific NMS treatments are the initial steps, rather than immediate ECT.\nE. Myocarditis: Clozapine can cause myocarditis, but the prominent feature of severe muscle rigidity with elevated CK points away from myocarditis as the primary diagnosis, although cardiac involvement can sometimes co-exist.\n\nOption B correctly identifies NMS as the most likely diagnosis and lists appropriate treatments (dantrolene and bromocriptine) in addition to discontinuing the offending agent implicitly by treating the syndrome. It is crucial to discontinue clozapine.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-008", "question": "A 45-year-old man with a history of relapsing-remitting multiple sclerosis presents with acute onset of bilateral leg weakness and urinary retention. MRI shows a new T2-hyperintense lesion at T10 with gadolinium enhancement. Despite high-dose intravenous methylprednisolone, symptoms worsen over 48 hours. CSF analysis reveals elevated IgG index and oligoclonal bands. What is the most appropriate next step in management?", "options": ["Initiate plasma exchange", "Administer rituximab", "Start fingolimod", "Perform lumbar puncture for repeat CSF analysis", "Switch to natalizumab"], "answer": "A", "answer_index": 0, "explanation": "Plasma exchange is the most appropriate next step for severe acute demyelinating attacks unresponsive to corticosteroids in multiple sclerosis, as it rapidly removes circulating autoantibodies and inflammatory mediators. Rituximab and natalizumab are disease-modifying therapies not indicated for acute management, while fingolimod is contraindicated in active inflammation; repeat CSF analysis is unnecessary with established diagnosis.", "generator_model": "grok-4-0709", "seed": 133, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "target_topic", "source_label_raw": "Neurology", "source_quiz_id": "20251225T231536524Z_grok-4-0709_seed133", "source_question_id": "20251225T231536524Z_grok-4-0709_seed133-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251225T231536524Z_grok-4-0709_seed133", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251225T231536524Z_grok-4-0709_seed133.jsonl", "pred": "A", "model_outputs": "NOT FOR CLINICAL USE.\nThe patient presents with a significant relapse of relapsing-remitting multiple sclerosis (RRMS) characterized by acute onset of bilateral leg weakness and urinary retention, with MRI evidence of an active, enhancing lesion in the spinal cord. Standard treatment for acute relapses in MS is high-dose intravenous methylprednisolone (IVMP). However, the patient's symptoms have worsened over 48 hours despite this treatment, indicating a steroid-refractory relapse. Cerebrospinal fluid (CSF) analysis showing an elevated IgG index and oligoclonal bands confirms active central nervous system inflammation consistent with MS but does not mandate further CSF analysis as a next step in this acute scenario.\n\nPlasma exchange (PLEX) is the recommended treatment for severe MS relapses that are refractory to high-dose corticosteroids. This patient meets the criteria for considering PLEX due to the severity of symptoms and lack of improvement with IVMP.\n\nRituximab, fingolimod, and natalizumab are disease-modifying therapies (DMTs) used to reduce the frequency and severity of future relapses and slow disease progression. While they are important treatments for MS, they are not indicated for the acute management of a steroid-refractory relapse. Starting a DMT now would not address the immediate worsening symptoms, and PLEX is the appropriate intervention for such a situation. Repeating CSF analysis is unnecessary as the diagnosis is established and the current presentation is clearly a relapse.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-009", "question": "A neonate with congenital diaphragmatic hernia undergoes surgical repair at 48 hours of life. Postoperatively, the infant develops persistent pulmonary hypertension with right-to-left shunting on echocardiography. Despite maximal ventilatory support and inhaled nitric oxide, oxygenation remains poor. What is the most appropriate next step in management?", "options": ["Initiation of extracorporeal membrane oxygenation", "Administration of intravenous milrinone", "High-frequency oscillatory ventilation trial", "Surgical revision of hernia repair", "Prostaglandin E1 infusion"], "answer": "A", "answer_index": 0, "explanation": "ECMO is indicated for refractory pulmonary hypertension in congenital diaphragmatic hernia when conventional therapies fail. Milrinone may help but is not superior to ECMO in severe cases; HFOV is already part of maximal support. Surgical revision or PGE1 is not appropriate without evidence of ductal dependency.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "The neonate has congenital diaphragmatic hernia (CDH) with persistent pulmonary hypertension (PPHN) and right-to-left shunting, leading to refractory hypoxemia despite maximal ventilatory support and inhaled nitric oxide (iNO). This indicates severe pulmonary vascular resistance and inadequate gas exchange from the lungs.\n\nLet's analyze the options:\nA. Initiation of extracorporeal membrane oxygenation (ECMO): ECMO is a life support system that mechanically oxygenates and ventilates the blood, bypassing the lungs. It is indicated for neonates with severe, refractory PPHN and hypoxemia when conventional and medical therapies (including advanced ventilation and iNO) have failed. CDH is a known indication for ECMO when pulmonary hypoplasia and PPHN are severe. Given the described refractory hypoxemia, ECMO is a strong candidate for the most appropriate next step.\n\nB. Administration of intravenous milrinone: Milrinone is a phosphodiesterase-3 inhibitor with inotropic and vasodilator effects. While it can cause pulmonary vasodilation, it is not typically the first-line or second-line treatment for refractory PPHN in neonates, especially compared to iNO and ECMO. Its role in neonatal PPHN is complex and generally less established for this severe scenario.\n\nC. High-frequency oscillatory ventilation (HFOV) trial: HFOV is an advanced mode of mechanical ventilation that can improve oxygenation in neonates with respiratory failure. However, the question states that the infant is already receiving \"maximal ventilatory support\" and that oxygenation \"remains poor.\" If \"maximal ventilatory support\" already includes HFOV, then this option might be insufficient or already tried. If it refers to conventional ventilation, then HFOV would be a logical consideration before ECMO. However, given the severity implied by persistent poor oxygenation despite iNO, ECMO may be more appropriate if HFOV is also failing or has not sufficiently improved oxygenation.\n\nD. Surgical revision of hernia repair: While complications from the repair could impact ventilation, the primary problem described is PPHN and shunting, which is a physiological issue related to the pulmonary vasculature common in CDH, rather than a direct surgical failure of the repair itself causing the PPHN, unless there is a specific mechanical complication not mentioned. ECMO is primarily a medical/supportive intervention.\n\nE. Prostaglandin E1 infusion: Prostaglandin E1 (PGE1) is used to maintain ductal patency in ductal-dependent congenital heart disease. In PPHN with right-to-left shunting through the ductus arteriosus, administering PGE1 would likely worsen hypoxemia by keeping the ductus open, thus promoting more shunting of deoxygenated blood. Therefore, this is contraindicated.\n\nConsidering that maximal ventilatory support and iNO have already failed, the infant is experiencing severe, life-threatening hypoxemia indicating complete failure of lung-based therapies. ECMO is the definitive life-support measure for such refractory cases, providing external oxygenation and ventilation, and acting as a bridge to native lung recovery or further intervention. Thus, ECMO is the most appropriate next step.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-010", "question": "A 2-year-old boy with hypoplastic left heart syndrome post-Norwood procedure presents with feeding intolerance and metabolic acidosis. Echocardiography shows preserved ventricular function but elevated right atrial pressure. Cardiac catheterization reveals stenosis at the neo-aortic arch. What is the most appropriate intervention?", "options": ["Balloon angioplasty of the arch stenosis", "Surgical arch augmentation", "Fontan completion procedure", "Heart transplantation evaluation", "Medical management with afterload reduction"], "answer": "B", "answer_index": 1, "explanation": "Surgical augmentation is preferred for neo-aortic arch stenosis in HLHS post-Norwood due to better long-term patency than balloon angioplasty, which has high restenosis rates. Fontan is premature; transplantation is for end-stage failure. Medical management does not address the anatomic issue.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-011", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "NOT FOR CLINICAL USE.\nThe patient is a 2-year-old boy with hypoplastic left heart syndrome (HLHS) status post-Norwood procedure. He presents with feeding intolerance and metabolic acidosis, clinical signs suggestive of poor systemic perfusion or increased metabolic demand due to cardiorespiratory stress. Echocardiography shows preserved ventricular function but elevated right atrial pressure, indicating increased systemic venous congestion, likely due to elevated afterload on the systemic ventricle (the right ventricle). Cardiac catheterization confirms stenosis at the neo-aortic arch, which is a common complication after the Norwood procedure. This stenosis increases the workload on the right ventricle, leading to reduced systemic output and subsequent hypoperfusion and venous congestion.\n\nThe most appropriate intervention targets the identified cause of the symptoms: the neo-aortic arch stenosis.\n\nLet's evaluate the options:\nA. Balloon angioplasty of the arch stenosis: This is a percutaneous intervention to dilate the narrowed segment of the neo-aortic arch. It is a less invasive approach than surgery and is typically the first-line treatment for significant aortic arch stenosis causing symptoms in these patients. Relieving the stenosis would reduce the afterload on the right ventricle, improve systemic perfusion, and alleviate the symptoms of feeding intolerance and metabolic acidosis, as well as reduce elevated right atrial pressure.\n\nB. Surgical arch augmentation: This involves open-heart surgery to directly reconstruct or enlarge the stenotic arch. While effective, it is more invasive than balloon angioplasty and is usually considered if angioplasty is unsuccessful or not feasible for complex lesions.\n\nC. Fontan completion procedure: The Fontan procedure is the final stage of palliation for single-ventricle physiology, which diverts systemic venous return directly to the pulmonary arteries. This patient is only 2 years old and has undergone the first stage (Norwood). Fontan completion is not indicated as the immediate intervention for arch stenosis. In fact, significant arch stenosis may need to be addressed prior to Fontan completion.\n\nD. Heart transplantation evaluation: Heart transplantation is a consideration for patients with HLHS who have severe ventricular dysfunction, intractable arrhythmias, or other unreconstructible lesions. However, image-identified and treatable lesions like arch stenosis are typically addressed first before considering transplantation.\n\nE. Medical management with afterload reduction: While afterload reduction might help reduce the workload on the right ventricle, it is unlikely to resolve significant mechanical obstruction like aortic arch stenosis. Medical management is supportive but not curative for this specific problem.\n\nGiven the findings, balloon angioplasty of the neo-aortic arch stenosis is the most appropriate and least invasive intervention to directly address the cause of the patient's symptoms and findings.\n\nThe answer is (A)"}]